Author Question: Which of the following is least likely to result in hypoglycemia in a type I diabetic patient? A) ... (Read 28 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
Which of the following is least likely to result in hypoglycemia in a type I diabetic patient?
 
  A) Increased exercise level
  B) Taking insulin as usual but missing a meal
  C) Eating foods high in sugar
  D) Inadvertently administering too much insulin

Question 2

You have been dispatched for a 61-year-old female in cardiac arrest. Emergency Medical Responders (EMRs) are on scene. In your community all EMS practitioners are trained according to the National EMS Scope of Practice Model. Which one of the following do you expect the EMRs to be providing?
 
  A) Emergency medication administration
  B) Automated external defibrillation
  C) Intravenous (IV) therapy
  D) Reading an electrocardiogram (ECG)


alvinum

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

C

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library